Public Health

What Does the NIH See in Bucks County Biotech?
Clinical & Pharma What Does the NIH See in Bucks County Biotech?

A high-stakes convergence of science and policy recently unfolded in Doylestown, Bucks County, as National Institutes of Health (NIH) Director Dr. Jay Bhattacharya accepted an invitation from Congressman Brian Fitzpatrick (PA-1) for a firsthand look at a thriving hub of biomedical innovation. The

Are You Protected From the Measles Outbreak?
Clinical & Pharma Are You Protected From the Measles Outbreak?

Health authorities have issued urgent warnings as the highly contagious measles virus continues its resurgence, with notable outbreaks reminding communities of the persistent threat posed by vaccine-preventable diseases. The ease of modern travel has transformed localized clusters into

South Africa Faces a Deadly Illicit Alcohol Crisis
Clinical & Pharma South Africa Faces a Deadly Illicit Alcohol Crisis

A pervasive shadow economy now accounts for nearly one out of every five alcoholic beverages consumed in South Africa, creating a multi-faceted crisis that poses an escalating threat to public health, economic stability, and national security. This thriving underground market, valued at an

Can Metabolism Assays Revolutionize Medicine?
Clinical & Pharma Can Metabolism Assays Revolutionize Medicine?

The intricate web of biochemical reactions occurring within our cells every second represents a foundational, yet often overlooked, frontier in medical science. Metabolism assays, the analytical tools designed to measure these vital processes, are emerging as a linchpin in the future of healthcare,

New Field Redefines the Science of Patient Survival
Clinical & Pharma New Field Redefines the Science of Patient Survival

A critical question is now reshaping how the medical community approaches patient care after a diagnosis, challenging a long-held assumption that the rules of disease prevention also apply to disease survival. For decades, research has focused intensely on identifying risk factors to help healthy

FDA Chief Sparks Uproar Over Vaccine Science
Clinical & Pharma FDA Chief Sparks Uproar Over Vaccine Science

Recent turmoil within the FDA has ignited a fierce debate over the future of vaccine regulation in the United States. A senior official’s internal memo, which critics describe as a break from long-standing scientific norms, has proposed a radical overhaul of how vaccines are approved and monitored.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later